SEC Form 4 · Rule 10b5-1 trading plans
Harmony Biosciences Holdings, Inc. (HRMY)
- 13Trades filed under a plan
- 0Plan adoption dates stated
- 11Quarterly results prints on file
- 1Trades in the days before a print
In the 2025 filing year, Harmony Biosciences Holdings, Inc. filed 9 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 3 reporting owners, covering 13 transactions filed under those plans and 135,549 shares. None carries the SEC's own AFF10B5ONE adoption flag; each of the 9 names a plan in a footnote. 11 results prints are on file in the same window, which is what makes the interval below measurable.
Trades filed under a plan in Harmony Biosciences Holdings, Inc. 13
- Dierks Jeffrey — 2025-01-13 · S · 7,180 shares
- Dierks Jeffrey — 2025-01-15 · S · 10,507 shares
- Dierks Jeffrey — 2025-01-16 · S · 29,475 shares
- Dayno Jeffrey M. — 2025-01-21 · S · 19,293 shares
- Dierks Jeffrey — 2025-01-21 · S · 1,123 shares
- Kapadia Sandip — 2025-01-21 · S · 25,000 shares
- Dierks Jeffrey — 2025-01-24 · S · 8,000 shares
- Dierks Jeffrey — 2025-01-24 · S · 5,125 shares
- Dierks Jeffrey — 2025-01-27 · S · 1,629 shares
- Kapadia Sandip — 2025-01-27 · S · 1,775 shares
- Dierks Jeffrey — 2025-03-03 · S · 4,369 shares
- Dierks Jeffrey — 2025-03-03 · S · 500 shares
Plan adoption dates stated in Harmony Biosciences Holdings, Inc. 0
Quarterly results prints on file in Harmony Biosciences Holdings, Inc. 11
- 2025-01-13
- 2025-02-25
- 2025-05-06
- 2025-08-05
- 2025-10-23
- 2025-11-04
- 2026-01-12
- 2026-02-24
- 2026-05-07
- 2026-07-16
- 2026-08-04
Trades in the days before a print in Harmony Biosciences Holdings, Inc. 1
- 0 days before the 2025-01-13 print — 2025-01-13 · S · Dierks Jeffrey · 7,180 shares
- 29 days before the 2025-02-25 print — 2025-01-27 · S · Dierks Jeffrey · 1,629 shares
- 29 days before the 2025-02-25 print — 2025-01-27 · S · Kapadia Sandip · 1,775 shares
- 32 days before the 2025-02-25 print — 2025-01-24 · S · Dierks Jeffrey · 8,000 shares
- 32 days before the 2025-02-25 print — 2025-01-24 · S · Dierks Jeffrey · 5,125 shares
- 35 days before the 2025-02-25 print — 2025-01-21 · S · Dayno Jeffrey M. · 19,293 shares
- 35 days before the 2025-02-25 print — 2025-01-21 · S · Dierks Jeffrey · 1,123 shares
- 35 days before the 2025-02-25 print — 2025-01-21 · S · Kapadia Sandip · 25,000 shares
- 40 days before the 2025-02-25 print — 2025-01-16 · S · Dierks Jeffrey · 29,475 shares
- 41 days before the 2025-02-25 print — 2025-01-15 · S · Dierks Jeffrey · 10,507 shares
- 64 days before the 2025-05-06 print — 2025-03-03 · S · Dierks Jeffrey · 4,369 shares
- 64 days before the 2025-05-06 print — 2025-03-03 · S · Dierks Jeffrey · 500 shares
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 1Within 5 days of a print
- 1Within 10 days of a print
- 0Shortest interval, in days
- 0Trades with no later print on file
- Dierks Jeffrey 2025-01-13 · S · 0 days before the 2025-01-13 print · CHIEF COMMERCIAL OFFICER
Reported results dates on file
- 2025-01-13
- 2025-02-25
- 2025-05-06
- 2025-08-05
- 2025-10-23
- 2025-11-04
- 2026-01-12
- 2026-02-24
- 2026-05-07
- 2026-07-16
- 2026-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 1
- FMC CORP 2
- ELI LILLY & Co 4
- ABEONA THERAPEUTICS INC. 2
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 12
- Lifevantage Corp 1
- IONIS PHARMACEUTICALS INC 29
- VERTEX PHARMACEUTICALS INC / MA 22
- ARROWHEAD PHARMACEUTICALS, INC. 9
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.